keratorhexis

Hello, you have come here looking for the meaning of the word keratorhexis. In DICTIOUS you will not only get to know all the dictionary meanings for the word keratorhexis, but we will also tell you about its etymology, its characteristics and you will know how to say keratorhexis in singular and plural. Everything you need to know about the word keratorhexis you have here. The definition of the word keratorhexis will help you to be more precise and correct when speaking or writing your texts. Knowing the definition ofkeratorhexis, as well as those of other words, enriches your vocabulary and provides you with more and better linguistic resources.

English

Etymology

From kerato- +‎ rhexis.

Noun

keratorhexis (uncountable)

  1. (medicine) Rupture of the cornea.
    • 1955, Charles I. Thomas, The cornea, page 249:
      This area then was flattened out near the sclera. It was not cone-shaped as in keratoconus, but cylindrical. In differential diagnosis Jauernig considered keratoconus, keratectasia and keratorhexis.
    • 2004 October, Udo Vanhoefer, Mitra Tewes, Federico Rojo, Olaf Dirsch, Norbert Schleucher, Oliver Rosen, Joachim Tillner, Andreas Kovar, Ada H. Braun, Tanja Trarbach, Siegfried Seeber, Andreas Harstrick, José Baselga, “Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor”, in Journal of Clinical Oncology:
      One patient experienced conjunctivitis-induced keratorhexis after multiple administrations of EMD72000 at DL 3 (1,200 mg), which resolved within 1 week after symptomatic treatment.
    • 2011 May, C. D. Weekes, P. LoRusso, V. Ramakrishnan, L. M. Shih, W. C. Darbonne, P. Hegde, Y. Xin, R. Yu, H. Xiang, R. K. Brachmann, A. Patnaik, “A phase Ib study for MNRP1685A (anti-NRP1) administered intravenously with bevacizumab with or without paclitaxel to patients with advanced solid tumors”, in Journal of Clinical Oncology, volume 29, number 15:
      Treatment-related grade 3-5 adverse events (AEs; cut-off date 11/23/10) included 1 sudden death, unknown etiology, at Day 7 in Arm A (36 mg/kg), neutropenia (n=4, all Arm B), proteinuria (n=3), thrombocytopenia (n=2), hypertension (n=2), and one each of fatigue, keratorhexis, and peripheral edema.